Morten Graugaard (CEO of Orbis Medicines)
ArticleDisrupting the biologics market through innovations in macrocycle R&D
New macrocycle technologies are turning a once difficult drug class into a scalable engine for developing potent oral therapies.
New macrocycle technologies are turning a once difficult drug class into a scalable engine for developing potent oral therapies.